Publicacións nas que colabora con FRANCISCO JAVIER GONZALEZ BARCALA (27)

2024

  1. Exploring CD26−/lo subpopulations of lymphocytes in asthma phenotype and severity: A novel CD4+ T cell subset expressing archetypical granulocyte proteins

    Allergy: European Journal of Allergy and Clinical Immunology

  2. Signature Proteins in Small Extracellular Vesicles of Granulocytes and CD4+ T-Cell Subpopulations Identified by Comparative Proteomic Analysis

    International Journal of Molecular Sciences, Vol. 25, Núm. 19

2023

  1. Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 223-231

  2. Prognostic Usefulness of Basic Analytical Data in Chronic Obstructive Pulmonary Disease Exacerbation

    Open Respiratory Archives, Vol. 5, Núm. 4

  3. Serum exosome inflamma-miRs are surrogate biomarkers for asthma phenotype and severity

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 1, pp. 141-155

2022

  1. Association of rhinitis with asthma prevalence and severity

    Scientific Reports, Vol. 12, Núm. 1

  2. Correction to: Impact of anxiety and depression on the prognosis of copd exacerbations (BMC Pulmonary Medicine, (2022), 22, 1, (169), 10.1186/s12890-022-01934-y)

    BMC Pulmonary Medicine

  3. Proteomic analysis of food allergens

    Food Proteomics: Technological Advances, Current Applications and Future Perspectives (Elsevier), pp. 225-300

  4. Risk Factors of Mortality in Hospitalized Patients With COVID-19 Applying a Machine Learning Algorithm

    Open Respiratory Archives, Vol. 4, Núm. 2

  5. The polyhedric reality of the interaction between COVID-19, asthma and inhaled corticosteroids

    ERJ Open Research

2021

  1. Blood eosinophil count as predictor of asthma exacerbation. A meta-analysis

    Pediatric Allergy and Immunology, Vol. 32, Núm. 3, pp. 465-478

  2. Clinical and inflammatory characteristics of patients with asthma in the Spanish MEGA project cohort

    Clinical and Translational Allergy, Vol. 11, Núm. 1

  3. Efficacy of mepolizumab in usual clinical practice and characteristics of responders: Mepolizumab in usual clinical practice

    Respiratory Medicine, Vol. 187

  4. Igf1r as a potential pharmacological target in allergic asthma

    Biomedicines, Vol. 9, Núm. 8

  5. Variability of blood eosinophil count and prognosis of COPD exacerbations

    Annals of Medicine, Vol. 53, Núm. 1, pp. 1152-1158

2020

  1. Equilibrio ácido-base

    Fisiología humana (McGraw Hill Education México)

  2. Obesity does not increase the risk of Asthma readmissions

    Journal of Clinical Medicine, Vol. 9, Núm. 1

  3. iTRAQ-based proteomic analysis reveals potential serum biomarkers of allergic and nonallergic asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 12, pp. 3171-3183

2019

  1. Expansion of different subpopulations of CD26 −/low T cells in allergic and non-allergic asthmatics

    Scientific Reports, Vol. 9, Núm. 1

  2. Blood eosinophils could be useful as a biomarker in chronic obstructive pulmonary disease exacerbations

    International Journal of Clinical Practice, Vol. 73, Núm. 12